Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Patient Information Leaflet last updated on the eMC: 03/02/2012
PIL Adalat LA 60 mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 13/08/2010 and displayed until 03/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
Updated on 06/05/2010 and displayed until 13/08/2010
Reasons for adding or updating:
  • Extra statutory information
Updated on 07/04/2009 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 28/10/2008 and displayed until 07/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 30/06/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 26/02/2008 and displayed until 30/06/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/01/2008 and displayed until 26/02/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 25/10/2006 and displayed until 24/01/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to date of revision
Updated on 28/07/2006 and displayed until 25/10/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to instructions about missed dose
  • Change to date of revision
Updated on 15/03/2005 and displayed until 28/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 20/01/2005 and displayed until 15/03/2005
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/01/2004 and displayed until 20/01/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 05/11/2002 and displayed until 23/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/09/2001 and displayed until 05/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 27/06/2000 and displayed until 25/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   nifedipine